Business Description
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Business History
Price Overview
Last updated: Jun 27, 2026 9:02am (just now)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): -1.41
Total Equity: $364.05M
Shares: 73,443,298
Total Debt: $16.41M
Cash: $230.52M
EBITDA: -$96.30M
Total Debt: $16.41M
Cash: $230.52M
Revenue: $255.87M
Shares: 73,443,298
Revenue: $255.87M
Revenue: $255.87M
Revenue: $255.87M
Total Equity: $364.05M
Tax Rate: -0.9%
Equity: $364.05M
Total Debt: $16.41M
Cash: $230.52M
Current Liabilities: $189.14M
Long-Term Debt: $0.00
Total Debt: $16.41M
Total Equity: $364.05M
Shares: 73,443,298
Shares: 73,443,298
CapEx: -$1.44M
Shares: 73,443,298
Stock Price: $16.86
Net Income: -$103.27M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 21, 2026 7:21pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $137.9M | $181.0M | $216.7M | $207.5M | $255.9M |
| Cost of Revenue | $72.3M | $79.9M | $76.0M | $75.5M | $113.3M |
| Gross Profit | $65.6M | $101.0M | $140.7M | $132.1M | $142.6M |
| Operating Expenses | $177.1M | $247.8M | $318.1M | $341.4M | $309.5M |
| Operating Income | -$111.4M | -$146.8M | -$177.4M | -$209.3M | -$166.9M |
| Net Income | -$100.4M | -$149.2M | $40.7M | -$187.1M | -$103.3M |
| EBITDA | -$98.0M | -$144.8M | $48.5M | -$179.6M | -$96.3M |
| EPS | $-1.43 | $-2.10 | $0.57 | $-2.57 | $-1.41 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 21, 2026 7:21pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $120.3M | $90.5M | $155.3M | $147.3M | $230.5M |
| Total Current Assets | $625.1M | $534.0M | $567.8M | $635.0M | $519.3M |
| Total Assets | $756.5M | $688.6M | $803.0M | $823.2M | $726.2M |
| Current Liabilities | $91.2M | $108.8M | $133.7M | $191.7M | $189.1M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $199.4M | $240.7M | $254.4M | $401.8M | $362.1M |
| Total Equity | $557.1M | $447.9M | $548.6M | $421.4M | $364.1M |
| Retained Earnings | -$230.0M | -$379.1M | -$338.4M | -$525.5M | -$628.8M |
Cash Flow (Annual)
Last updated: Jun 21, 2026 7:21pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$70.7M | -$119.7M | -$136.7M | -$157.4M | $13.9M |
| Capital Expenditure | -$7.2M | -$8.0M | -$13.4M | -$7.3M | -$1.4M |
| Free Cash Flow | -$77.8M | -$127.7M | -$150.1M | -$164.7M | $12.5M |
| Acquisitions (net) | $0 | -$7.0M | -$4.1M | $45.7M | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$79.5M | -$27.6M | $65.3M | $1.6M | $74.7M |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 9:02am (just now)| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue |
$264.6M $222.4M – $341.3M
|
$322.5M $315.4M – $329.7M
|
$371.8M $337.5M – $448.9M
|
$406.5M $369.0M – $490.8M
|
| EBITDA |
-$133.8M -$172.6M – -$112.4M
|
-$163.1M -$166.7M – -$159.5M
|
-$188.0M -$227.0M – -$170.7M
|
-$205.5M -$248.2M – -$186.6M
|
| Net Income |
-$88.2M -$194.5M – $39.1M
|
-$5.5M -$47.7M – $64.6M
|
$-734,432 $-932,450 – $-646,429
|
$29.4M $25.9M – $37.3M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 21, 2026 7:21pm (5d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +31.2% | +19.7% | -4.2% | +23.3% |
| Gross Profit Growth | +54.0% | +39.3% | -6.1% | +8.0% |
| Operating Income Growth | -31.7% | -20.9% | -17.9% | +20.3% |
| Net Income Growth | -48.6% | +127.3% | -559.5% | +44.8% |
| EBITDA Growth | -47.8% | +133.5% | -470.4% | +46.4% |
Insider Trading (Recent)
All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-22 | OBEROI ARUN | A-Award | 8,141.00 | $0.00 | $0 |
| 2026-06-22 | OBEROI ARUN | A-Award | 13,313.00 | $15.23 | $202,757 |
| 2026-06-22 | Chodakewitz Jeffrey | A-Award | 8,141.00 | $0.00 | $0 |
| 2026-06-22 | Chodakewitz Jeffrey | A-Award | 13,313.00 | $15.23 | $202,757 |
| 2026-06-22 | Friesner Richard | A-Award | 8,141.00 | $0.00 | $0 |
| 2026-06-22 | Friesner Richard | A-Award | 13,313.00 | $15.23 | $202,757 |
| 2026-06-22 | GINSBERG GARY L | A-Award | 8,141.00 | $0.00 | $0 |
| 2026-06-22 | GINSBERG GARY L | A-Award | 13,313.00 | $15.23 | $202,757 |
| 2026-06-22 | Kapeller-Libermann Rosana | A-Award | 8,141.00 | $0.00 | $0 |
| 2026-06-22 | Kapeller-Libermann Rosana | A-Award | 13,313.00 | $15.23 | $202,757 |
| 2026-06-22 | Lynton Michael | A-Award | 8,141.00 | $0.00 | $0 |
| 2026-06-22 | Lynton Michael | A-Award | 13,313.00 | $15.23 | $202,757 |
| 2026-06-22 | Sender Gary | A-Award | 8,141.00 | $0.00 | $0 |
| 2026-06-22 | Sender Gary | A-Award | 13,313.00 | $15.23 | $202,757 |
| 2026-06-22 | Thornberry Nancy | A-Award | 8,141.00 | $0.00 | $0 |
| 2026-06-22 | Thornberry Nancy | A-Award | 13,313.00 | $15.23 | $202,757 |
| 2026-06-22 | van Kralingen Bridget A | A-Award | 8,141.00 | $0.00 | $0 |
| 2026-06-22 | van Kralingen Bridget A | A-Award | 13,313.00 | $15.23 | $202,757 |
| 2026-04-17 | Farid Ramy | M-Exempt | 74,527.00 | $3.07 | $228,798 |
| 2026-04-17 | Farid Ramy | M-Exempt | 43,000.00 | $3.07 | $132,010 |
Narrative Economics
market-narrative step).